420 related articles for article (PubMed ID: 11292337)
1. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.
Heddle JG; Blance SJ; Zamble DB; Hollfelder F; Miller DA; Wentzell LM; Walsh CT; Maxwell A
J Mol Biol; 2001 Apr; 307(5):1223-34. PubMed ID: 11292337
[TBL] [Abstract][Full Text] [Related]
2. Construction and characterization of mutations at codon 751 of the Escherichia coli gyrB gene that confer resistance to the antimicrobial peptide microcin B17 and alter the activity of DNA gyrase.
del Castillo FJ; del Castillo I; Moreno F
J Bacteriol; 2001 Mar; 183(6):2137-40. PubMed ID: 11222617
[TBL] [Abstract][Full Text] [Related]
3. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
[TBL] [Abstract][Full Text] [Related]
4. The interaction of DNA gyrase with the bacterial toxin CcdB: evidence for the existence of two gyrase-CcdB complexes.
Kampranis SC; Howells AJ; Maxwell A
J Mol Biol; 1999 Oct; 293(3):733-44. PubMed ID: 10543963
[TBL] [Abstract][Full Text] [Related]
5. The F plasmid CcdB protein induces efficient ATP-dependent DNA cleavage by gyrase.
Bernard P; Kézdy KE; Van Melderen L; Steyaert J; Wyns L; Pato ML; Higgins PN; Couturier M
J Mol Biol; 1993 Dec; 234(3):534-41. PubMed ID: 8254658
[TBL] [Abstract][Full Text] [Related]
6. Locking the ATP-operated clamp of DNA gyrase: probing the mechanism of strand passage.
Williams NL; Howells AJ; Maxwell A
J Mol Biol; 2001 Mar; 306(5):969-84. PubMed ID: 11237612
[TBL] [Abstract][Full Text] [Related]
7. The complex of DNA gyrase and quinolone drugs on DNA forms a barrier to the T7 DNA polymerase replication complex.
Wentzell LM; Maxwell A
J Mol Biol; 2000 Dec; 304(5):779-91. PubMed ID: 11124026
[TBL] [Abstract][Full Text] [Related]
8. The interaction of the F plasmid killer protein, CcdB, with DNA gyrase: induction of DNA cleavage and blocking of transcription.
Critchlow SE; O'Dea MH; Howells AJ; Couturier M; Gellert M; Maxwell A
J Mol Biol; 1997 Nov; 273(4):826-39. PubMed ID: 9367775
[TBL] [Abstract][Full Text] [Related]
9. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
Chen CR; Malik M; Snyder M; Drlica K
J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
[TBL] [Abstract][Full Text] [Related]
10. The action of the bacterial toxin microcin B17. Insight into the cleavage-religation reaction of DNA gyrase.
Pierrat OA; Maxwell A
J Biol Chem; 2003 Sep; 278(37):35016-23. PubMed ID: 12829716
[TBL] [Abstract][Full Text] [Related]
11. The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase.
Willmott CJ; Critchlow SE; Eperon IC; Maxwell A
J Mol Biol; 1994 Sep; 242(4):351-63. PubMed ID: 7932695
[TBL] [Abstract][Full Text] [Related]
12. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis.
Hammonds TR; Foster SR; Maxwell A
J Mol Biol; 2000 Jul; 300(3):481-91. PubMed ID: 10884345
[TBL] [Abstract][Full Text] [Related]
13. The phytotoxin albicidin is a novel inhibitor of DNA gyrase.
Hashimi SM; Wall MK; Smith AB; Maxwell A; Birch RG
Antimicrob Agents Chemother; 2007 Jan; 51(1):181-7. PubMed ID: 17074789
[TBL] [Abstract][Full Text] [Related]
14. Effect of different classes of inhibitors on DNA gyrase from Mycobacterium smegmatis.
Chatterji M; Unniraman S; Mahadevan S; Nagaraja V
J Antimicrob Chemother; 2001 Oct; 48(4):479-85. PubMed ID: 11581225
[TBL] [Abstract][Full Text] [Related]
15. The peptide antibiotic microcin B17 induces double-strand cleavage of DNA mediated by E. coli DNA gyrase.
Vizán JL; Hernández-Chico C; del Castillo I; Moreno F
EMBO J; 1991 Feb; 10(2):467-76. PubMed ID: 1846808
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the role of DNA strand passage in the mechanism of action of microcin B17 on DNA gyrase.
Pierrat OA; Maxwell A
Biochemistry; 2005 Mar; 44(11):4204-15. PubMed ID: 15766248
[TBL] [Abstract][Full Text] [Related]
17. DNA cleavage is not required for the binding of quinolone drugs to the DNA gyrase-DNA complex.
Critchlow SE; Maxwell A
Biochemistry; 1996 Jun; 35(23):7387-93. PubMed ID: 8652515
[TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of DNA gyrase inhibition by microcin B17 analogs with altered bisheterocyclic sites.
Zamble DB; Miller DA; Heddle JG; Maxwell A; Walsh CT; Hollfelder F
Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7712-7. PubMed ID: 11427730
[TBL] [Abstract][Full Text] [Related]
19. Chromosomally encoded gyrase inhibitor GyrI protects Escherichia coli against DNA-damaging agents.
Chatterji M; Sengupta S; Nagaraja V
Arch Microbiol; 2003 Nov; 180(5):339-46. PubMed ID: 13680098
[TBL] [Abstract][Full Text] [Related]
20. Peptides based on CcdB protein as novel inhibitors of bacterial topoisomerases.
Trovatti E; Cotrim CA; Garrido SS; Barros RS; Marchetto R
Bioorg Med Chem Lett; 2008 Dec; 18(23):6161-4. PubMed ID: 18938079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
